Cargando…

New Technology for the Use of Inhaled Nitric Oxide to Protect the Heart and Lungs during Operations with Cardiopulmonary Bypass

The aim of the study was to evaluate the effectiveness of a new technology for the use of inhaled nitric oxide (NO) for the heart and lung protection during operations with cardiopulmonary bypass (СРВ). MATERIALS AND METHODS. The study included 90 patients who underwent heart valve surgery and combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pichugin, V.V., Seyfetdinov, I.R., Ryazanov, M.V., Domnin, S.E., Gamzaev, A.B., Chiginev, V.A., Bober, V.V., Medvedev, A.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Privolzhsky Research Medical University 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596258/
https://www.ncbi.nlm.nih.gov/pubmed/34796002
http://dx.doi.org/10.17691/stm2020.12.5.03
_version_ 1784600325115609088
author Pichugin, V.V.
Seyfetdinov, I.R.
Ryazanov, M.V.
Domnin, S.E.
Gamzaev, A.B.
Chiginev, V.A.
Bober, V.V.
Medvedev, A.P.
author_facet Pichugin, V.V.
Seyfetdinov, I.R.
Ryazanov, M.V.
Domnin, S.E.
Gamzaev, A.B.
Chiginev, V.A.
Bober, V.V.
Medvedev, A.P.
author_sort Pichugin, V.V.
collection PubMed
description The aim of the study was to evaluate the effectiveness of a new technology for the use of inhaled nitric oxide (NO) for the heart and lung protection during operations with cardiopulmonary bypass (СРВ). MATERIALS AND METHODS. The study included 90 patients who underwent heart valve surgery and combined procedures under CPB and pharmacological cardioplegia. Three groups were created: group 1 (control, n=30); group 2 (n=30) — NO inhalation (20 ppm) was conducted traditionally, that is, before and after CPB; group 3 (n=30) — NO inhalation was performed using a new technology — during the entire operation, with pulmonary artery perfusion and lung ventilation performed during CPB. Troponin I (cTn I) level, changes in the pulmonary function parameters, and clinical indicators were studied. RESULTS. Statistically significant lower levels of postoperative cTn I were registered in the patients of groups 2 and 3, at the same time, the levels were significantly lower in group 3 compared to group 2. The patients in group 1 (standardized anesthesia protocol) demonstrated an increase in the alveolar-arterial oxygen difference, an increase in intrapulmonary shunting, a decrease in blood oxygenation, and static lung compliance after СРВ. In both cases, NO inhalation retained the values of lung compliance and pulmonary oxygenating function after CPB, and in the patients of group 3, it also significantly reduced intrapulmonary shunting and alveolar-arterial difference after CPB. NO inhalation allowed a statistically significant decrease in the incidence of pulmonary dysfunction, acute respiratory failure, as well as the time of respiratory support in the ICU. CONCLUSION. The developed technology for the use of inhaled NO in surgery with CPB provides a clinically marked protective effect on the heart and lungs. The effectiveness of the protective action of NO depends on the duration of its administration and is most pronounced when used during the entire operation, including CPB time.
format Online
Article
Text
id pubmed-8596258
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Privolzhsky Research Medical University
record_format MEDLINE/PubMed
spelling pubmed-85962582021-11-17 New Technology for the Use of Inhaled Nitric Oxide to Protect the Heart and Lungs during Operations with Cardiopulmonary Bypass Pichugin, V.V. Seyfetdinov, I.R. Ryazanov, M.V. Domnin, S.E. Gamzaev, A.B. Chiginev, V.A. Bober, V.V. Medvedev, A.P. Sovrem Tekhnologii Med Advanced Researches The aim of the study was to evaluate the effectiveness of a new technology for the use of inhaled nitric oxide (NO) for the heart and lung protection during operations with cardiopulmonary bypass (СРВ). MATERIALS AND METHODS. The study included 90 patients who underwent heart valve surgery and combined procedures under CPB and pharmacological cardioplegia. Three groups were created: group 1 (control, n=30); group 2 (n=30) — NO inhalation (20 ppm) was conducted traditionally, that is, before and after CPB; group 3 (n=30) — NO inhalation was performed using a new technology — during the entire operation, with pulmonary artery perfusion and lung ventilation performed during CPB. Troponin I (cTn I) level, changes in the pulmonary function parameters, and clinical indicators were studied. RESULTS. Statistically significant lower levels of postoperative cTn I were registered in the patients of groups 2 and 3, at the same time, the levels were significantly lower in group 3 compared to group 2. The patients in group 1 (standardized anesthesia protocol) demonstrated an increase in the alveolar-arterial oxygen difference, an increase in intrapulmonary shunting, a decrease in blood oxygenation, and static lung compliance after СРВ. In both cases, NO inhalation retained the values of lung compliance and pulmonary oxygenating function after CPB, and in the patients of group 3, it also significantly reduced intrapulmonary shunting and alveolar-arterial difference after CPB. NO inhalation allowed a statistically significant decrease in the incidence of pulmonary dysfunction, acute respiratory failure, as well as the time of respiratory support in the ICU. CONCLUSION. The developed technology for the use of inhaled NO in surgery with CPB provides a clinically marked protective effect on the heart and lungs. The effectiveness of the protective action of NO depends on the duration of its administration and is most pronounced when used during the entire operation, including CPB time. Privolzhsky Research Medical University 2020 2020-10-28 /pmc/articles/PMC8596258/ /pubmed/34796002 http://dx.doi.org/10.17691/stm2020.12.5.03 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Advanced Researches
Pichugin, V.V.
Seyfetdinov, I.R.
Ryazanov, M.V.
Domnin, S.E.
Gamzaev, A.B.
Chiginev, V.A.
Bober, V.V.
Medvedev, A.P.
New Technology for the Use of Inhaled Nitric Oxide to Protect the Heart and Lungs during Operations with Cardiopulmonary Bypass
title New Technology for the Use of Inhaled Nitric Oxide to Protect the Heart and Lungs during Operations with Cardiopulmonary Bypass
title_full New Technology for the Use of Inhaled Nitric Oxide to Protect the Heart and Lungs during Operations with Cardiopulmonary Bypass
title_fullStr New Technology for the Use of Inhaled Nitric Oxide to Protect the Heart and Lungs during Operations with Cardiopulmonary Bypass
title_full_unstemmed New Technology for the Use of Inhaled Nitric Oxide to Protect the Heart and Lungs during Operations with Cardiopulmonary Bypass
title_short New Technology for the Use of Inhaled Nitric Oxide to Protect the Heart and Lungs during Operations with Cardiopulmonary Bypass
title_sort new technology for the use of inhaled nitric oxide to protect the heart and lungs during operations with cardiopulmonary bypass
topic Advanced Researches
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596258/
https://www.ncbi.nlm.nih.gov/pubmed/34796002
http://dx.doi.org/10.17691/stm2020.12.5.03
work_keys_str_mv AT pichuginvv newtechnologyfortheuseofinhalednitricoxidetoprotecttheheartandlungsduringoperationswithcardiopulmonarybypass
AT seyfetdinovir newtechnologyfortheuseofinhalednitricoxidetoprotecttheheartandlungsduringoperationswithcardiopulmonarybypass
AT ryazanovmv newtechnologyfortheuseofinhalednitricoxidetoprotecttheheartandlungsduringoperationswithcardiopulmonarybypass
AT domninse newtechnologyfortheuseofinhalednitricoxidetoprotecttheheartandlungsduringoperationswithcardiopulmonarybypass
AT gamzaevab newtechnologyfortheuseofinhalednitricoxidetoprotecttheheartandlungsduringoperationswithcardiopulmonarybypass
AT chiginevva newtechnologyfortheuseofinhalednitricoxidetoprotecttheheartandlungsduringoperationswithcardiopulmonarybypass
AT bobervv newtechnologyfortheuseofinhalednitricoxidetoprotecttheheartandlungsduringoperationswithcardiopulmonarybypass
AT medvedevap newtechnologyfortheuseofinhalednitricoxidetoprotecttheheartandlungsduringoperationswithcardiopulmonarybypass